UB Therapeutics Ltd.

www.ub-therapeutics.com

High-Tech Company

Graduated from: NGT Healthcare II

TECH VERTICALS

Cancer, Life Sciences, MedTech, Pharmaceuticals

General Data

Sector	Biomed
Company Stage:	R&D
Established	2023
Number of Employees	6
Reg. Number:	abCDe

DESCRIPTION

UB Therapeutics is a pioneering company developing novel cyclic peptides with a distinct mode of action to target key mechanisms in multiple myeloma.

TECHNOLOGY

A new proteasome degradation inhibitor drug candidate with a distinct mode of action for the treatment of Multiple myeloma (MM).

Products and Phases

Product	Phase
UB Therapeutics proteasome degradation inhibitor	Phase I
UB Therapeutics is currently developing a new proteasome degradation inhibitor drug candidate with a distinct mode of action for the treatment of Multiple myeloma (MM)

	TARGET MARKETS
	Hospitals

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Nazareth, Israel

Address	C/O NGT Healthcare II, Nazareth Industrial Area, Wadi El Haj 13
POB	1252
City	Nazareth
Country	Israel
Zip	1711102

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Dima Ghannam-Shahbari	CEO & Co-Founder
Prof. Ashraf Brik	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Managing Partner & CFO, NGT3VC
abC Defghij	Board Member	CEO, NGT3VC
abC Defghij	Board Member	Former President, Technion

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Feb. 01, 2023

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Technology Transfer Company	abCDe
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

May. 01, 2024

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe